Kevin Kia, MD
Dermatology · Garland, TXNPI 1700088804
Payments from drug & device makers
Across 606 payments — averaging $549.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$233K
- Galderma Laboratories, L.p.$93K
- Sanofi$2K
- UCB, Inc.$854
- Incyte Corporation$433
- Endo USA, Inc.$420
- plus $3K from 23 others
Across 8 payments — averaging $152.29 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$1K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 274 | $232,649 |
| Galderma Laboratories, L.p. | 123 | $92,531 |
| Sanofi | 59 | $2,471 |
| UCB, Inc. | 14 | $854 |
| Incyte Corporation | 10 | $433 |
| Endo USA, Inc. | 1 | $420 |
| Regeneron Healthcare Solutions, Inc. | 30 | $406 |
| Chugai Pharmaceutical Co., Ltd. | 1 | $400 |
| Lilly USA, LLC | 4 | $326 |
| LEO Pharma Inc. | 13 | $306 |
| Dermavant Sciences, Inc. | 29 | $273 |
| Amgen | 6 | $239 |
| Pfizer | 3 | $179 |
| Boehringer Ingelheim | 4 | $171 |
| Organon | 14 | $169 |
| Janssen Scientific Affairs, LLC | 1 | $144 |
| E.r. Squibb & Sons, L.L.C. | 1 | $137 |
| Blueprint Medicines Corporation | 1 | $122 |
| VYNE Pharmaceuticals Inc. | 1 | $122 |
| Kyowa Kirin, Inc. | 1 | $121 |
| Novartis | 4 | $84 |
| Arcutis Biotherapeutics, Inc. | 3 | $54 |
| Sun Pharmaceutical Industries Inc. | 3 | $50 |
| Cipher Pharmaceuticals US LLC | 1 | $23 |
| Journey Medical Corporation | 1 | $22 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $19 |
| Almirall LLC | 1 | $16 |
| Botanix SB Inc | 1 | $15 |
| Johnson & Johnson | 1 | $14 |
How this compares
$332,771 in reported general payments places this provider in the 95th percentile of 1,098 dermatology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other dermatology in Garland
- Stephen TyringWebster$14.1M
- Edward LainAustin$12M
- Mark LeeSan Antonio$10.9M
- John BrowningSan Antonio$10.7M
- Craig TellerBellaire$7.7M
- Patricia LeeWebster$7.2M
- Jennifer CatherDallas$4.9M
- Michael MigdenHouston$3.7M
- Martin MenterDallas$3.7M
- Janet DuboisAustin$3.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.